BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 30978414)

  • 21. Routine cervical screening by primary HPV testing: early findings in the renewed National Cervical Screening Program.
    Machalek DA; Roberts JM; Garland SM; Thurloe J; Richards A; Chambers I; Sivertsen T; Farnsworth A
    Med J Aust; 2019 Aug; 211(3):113-119. PubMed ID: 31168828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of increasing cervical cancer screening coverage in the Middle East: An example from Lebanon.
    Sharma M; Seoud M; Kim JJ
    Vaccine; 2017 Jan; 35(4):564-569. PubMed ID: 28017434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prior cervical cytology and high-risk HPV testing results for 311 patients with invasive cervical adenocarcinoma: a multicenter retrospective study from China's largest independent operator of pathology laboratories.
    Xie F; Zhang L; Zhao D; Wu X; Wei M; Zhang X; Wu X; Fang H; Xu X; Yang M; Qi D
    BMC Infect Dis; 2019 Nov; 19(1):962. PubMed ID: 31711435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. European consensus statement on "HPV Vaccination and Colposcopy".
    Shafi MI; Petry U; Bosch XF; Gissman L; Kocken M; Helmerhorst TJ; Stanley M; Nazeer S; European Federation for Colposcopy
    J Low Genit Tract Dis; 2011 Oct; 15(4):309-15. PubMed ID: 21959574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cervical cancer screening cotesting with cytology and MRNA HPV E6/E7 yields high rates of CIN2+ lesions in young women.
    Granados R; Tellez-Safina H; Solis I; Mateos F; Rodriguez-Barbero JM; Aramburu JA; Huertas MA; Bajo P; Camarmo E; Corrales T; Medina P; Calvo B; Martin E; Anta L; Zamora M; Alcaide T
    Diagn Cytopathol; 2017 Dec; 45(12):1065-1072. PubMed ID: 28949442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HPV for cervical cancer screening (HPV FOCAL): Complete Round 1 results of a randomized trial comparing HPV-based primary screening to liquid-based cytology for cervical cancer.
    Ogilvie GS; Krajden M; van Niekerk D; Smith LW; Cook D; Ceballos K; Lee M; Gentile L; Gondara L; Elwood-Martin R; Peacock S; Stuart G; Franco EL; Coldman AJ
    Int J Cancer; 2017 Jan; 140(2):440-448. PubMed ID: 27685757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eight-type human papillomavirus E6/E7 oncoprotein detection as a novel and promising triage strategy for managing HPV-positive women.
    Rezhake R; Hu SY; Zhao S; Xu XQ; Zhao XL; Zhang L; Wang Y; Zhang X; Pan QJ; Qiao YL; Zhao FH
    Int J Cancer; 2019 Jan; 144(1):34-42. PubMed ID: 29943809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
    Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
    Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of cervical cancer prevention in Central and Eastern Europe and Central Asia.
    Berkhof J; Bogaards JA; Demirel E; Diaz M; Sharma M; Kim JJ
    Vaccine; 2013 Dec; 31 Suppl 7():H71-9. PubMed ID: 24332299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of multiple primary and combination screening strategies in postmenopausal women for detection of cervical cancer in China.
    Holt HK; Zhang L; Zhao FH; Hu SY; Zhao XL; Zhang X; Pan QJ; Zhang WH; Smith JS; Qiao YL
    Int J Cancer; 2017 Feb; 140(3):544-554. PubMed ID: 27727464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Triage of women with negative cytology and positive high-risk HPV: an analysis of data from the SHENCCAST II/III studies.
    Goodrich SK; Pretorius RG; Du H; Wu R; Belinson JL
    J Low Genit Tract Dis; 2014 Apr; 18(2):122-7. PubMed ID: 24270196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What Role Should Cytology Play in Cervical Cancer Screening?
    Perkins RB; Austin RM; Zhao C; Saslow D; Massad LS
    J Low Genit Tract Dis; 2019 Jul; 23(3):205-209. PubMed ID: 31135652
    [No Abstract]   [Full Text] [Related]  

  • 33. Should We Always Look Before We LEEP? A Discussion of the Pros and Cons of Colposcopic Biopsy Prior to Treatment.
    Guido R; Perkins RB; Smith KM
    J Low Genit Tract Dis; 2019 Apr; 23(2):147-150. PubMed ID: 30817690
    [No Abstract]   [Full Text] [Related]  

  • 34. Primary HPV screening for cervical cancer.
    Bhatla N; Singhal S
    Best Pract Res Clin Obstet Gynaecol; 2020 May; 65():98-108. PubMed ID: 32291178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cervical Cancer Screening: More Choices in 2019.
    Sawaya GF; Smith-McCune K; Kuppermann M
    JAMA; 2019 May; 321(20):2018-2019. PubMed ID: 31135834
    [No Abstract]   [Full Text] [Related]  

  • 36. Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans.
    Maver PJ; Poljak M
    Clin Microbiol Infect; 2020 May; 26(5):579-583. PubMed ID: 31539637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular mechanisms in progression of HPV-associated cervical carcinogenesis.
    Gupta SM; Mania-Pramanik J
    J Biomed Sci; 2019 Apr; 26(1):28. PubMed ID: 31014351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human Papillomavirus genotypes distribution and associated risk factors among women living in Southern Morocco.
    Rogua H; Ferrera L; El Mansouri N; Kassidi F; Aksim M; Aghrouch M; Nejmeddine M; Chouham S
    Heliyon; 2023 Nov; 9(11):e22497. PubMed ID: 38074872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening for the prevention and early detection of cervical cancer: protocol for systematic reviews to inform Canadian recommendations.
    Gates A; Pillay J; Reynolds D; Stirling R; Traversy G; Korownyk C; Moore A; Thériault G; Thombs BD; Little J; Popadiuk C; van Niekerk D; Keto-Lambert D; Vandermeer B; Hartling L
    Syst Rev; 2021 Jan; 10(1):2. PubMed ID: 33388083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acceptability of self- collection for human papillomavirus detection in the Eastern Cape, South Africa.
    Taku O; Meiring TL; Gustavsson I; Phohlo K; Garcia-Jardon M; Mbulawa ZZA; Businge CB; Gyllensten U; Williamson AL
    PLoS One; 2020; 15(11):e0241781. PubMed ID: 33170891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.